| 11851429 |
AMPK activators |
Iyassu Sebhat, Shuwen He, Nancy A. Thornberry, Lisa KRUG, Paul RICHARDS +1 more |
2023-12-26 |
|
| 9732111 |
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
Frank Bennett, Yuhua Huang, Lingyan Wang, Stephane L. Bogen, Angela Dawn Kerekes +4 more |
2017-08-15 |
$57,816,000 |
| 9403790 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Ping Chen |
2016-08-02 |
$113,135,000 |
| 9278976 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
Tesfaye Biftu |
2016-03-08 |
$114,032,000 |
| 9138426 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
Tesfaye Biftu |
2015-09-22 |
$66,869,000 |
| 9073930 |
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2015-07-07 |
$67,990,000 |
| 8951965 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2015-02-10 |
$89,040,000 |
| 8772328 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2014-07-08 |
$92,685,000 |
| 8716482 |
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
Jason M. Cox, Tesfaye Biftu, Hong Dong Chu, Danqing Feng |
2014-05-06 |
$63,658,000 |
| 8653059 |
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Danqing Feng, Jason M. Cox, Xiaoxia Qian, Jinyou Xu |
2014-02-18 |
$166,154,000 |
| 8592371 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2013-11-26 |
$55,727,000 |
| 8440668 |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
Scott D. Edmondson, Michael H. Fisher, Dooseop Kim, Malcolm MacCoss, Emma R. Parmee +1 more |
2013-05-14 |
$107,206,000 |
| 8415297 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2013-04-09 |
$69,688,000 |
| 8168637 |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes |
Scott D. Edmondson, Dooseop Kim, Malcolm MacCoss, Emma R. Parmee, Jinyou Xu |
2012-05-01 |
$48,747,000 |
| 8143289 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Ping Chen, Jason M. Cox |
2012-03-27 |
$58,464,000 |
| 7956061 |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Wallace T. Ashton, Charles G. Caldwell, Hong Dong, Ying-Duo Gao, Giovanna Scapin |
2011-06-07 |
$136,906,000 |
| 7928112 |
Substituted 5,6,7,8-tetrahydropyrido[4,3-D]pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Ping Chen, Danqing Feng |
2011-04-19 |
$39,939,000 |
| 7910596 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Charles G. Caldwell, Ping Chen, Xiaoxia Qian, Danqing Feng +1 more |
2011-03-22 |
$69,162,000 |
| 7906649 |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
Tesfaye Biftu, Danqing Feng, Xiaoxia Qian, Jason M. Cox |
2011-03-15 |
$44,210,000 |
| 7884104 |
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Jason M. Cox, Scott D. Edmondson, Bart Harper |
2011-02-08 |
$84,886,000 |
| 7812027 |
Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Ping Chen, Danqing Feng |
2010-10-12 |
$104,397,000 |
| 7750034 |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu, Jason M. Cox, Danqing Feng, Anthony Mastracchio, Xiaoxia Qian |
2010-07-06 |
$142,087,000 |
| 7678905 |
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Tesfaye Biftu |
2010-03-16 |
$69,781,000 |
| 7671073 |
Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Joseph L. Duffy, David E. Kaelin, Brian Kirk |
2010-03-02 |
$119,161,000 |
| 7625888 |
Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
Wallace T. Ashton |
2009-12-01 |
$78,669,000 |
